Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
313 studies found for:    Open Studies | "Carcinoma, Renal Cell"
Show Display Options
Rank Status Study
21 Recruiting Phase 1/2 Study of Tivozanib in Combination With Nivolumab in Subjects With RCC
Condition: Carcinoma, Renal Cell
Interventions: Drug: Tivozanib;   Drug: Nivolumab
22 Recruiting Dose-Finding, Safety and Efficacy Study of RX-0201 Plus Everolimus in Metastatic Renal Cell Cancer
Condition: Metastatic Renal Cell Cancer
Interventions: Drug: RX-0201;   Drug: Everolimus
23 Recruiting Stereotactic Radiotherapy for Metastatic Kidney Cancer Being Treated With Sunitinib
Condition: Clear Cell Metastatic Renal Cell Carcinoma
Intervention: Radiation: Stereotactic radiotherapy
24 Recruiting Molecular Determinants for Therapy Response on Renal Cell Carcinoma
Condition: Renal Cell Carcinoma
Intervention: Drug: Sunitinib, Pazopanib, Bevacizumab, Everolimus...
25 Recruiting Study On Fatigue- And Hand-Foot Syndrome-Related Quality Of Life In Patients With Metastatic Renal Cell Carcinoma Receiving A Tyrosine Kinase Inhibitor as First-Line Treatment
Condition: Metastatic Renal Cell Carcinoma
26 Recruiting Post Marketing Surveillance for PROSENSE™ a Cryotherapy Treatment of Renal Cell Carcinoma
Condition: Renal Cell Carcinoma
Intervention: Device: PROSENSE™
27 Recruiting Ablative tReatment of Inoperable REnal Cell Carcinoma Using STereotactic Body Radiotherapy (ARREST-study)
Condition: Renal Cell Carcinoma
Intervention: Radiation: ARREST-study
28 Recruiting Study of High Dose Interleukin-2 (IL-2) and Stereotactic Body Radiation (SBRT) in Patients With Metastatic Renal Cancer
Condition: Renal Cell Carcinoma
Interventions: Biological: High Dose IL-2;   Radiation: SBRT
29 Recruiting A Study of Anti-PD1 (Nivolumab) Therapy as Pre- and Post-operative Therapy in Metastatic Renal Cell Cancer (ADAPTeR)
Condition: Renal Cell Carcinoma
Intervention: Drug: nivolumab
30 Recruiting Phase Ib/II Trial of Interleukin-2 and PD-1 Checkpoint Inhibitor, Nivolumab In Metastatic Clear Cell Renal Cell Cancer
Condition: Renal Cell Carcinoma
Interventions: Drug: Interleukin-2;   Drug: Nivolumab
31 Recruiting A Study Evaluating the Effect of Pembrolizumab (MK-3475) in Participants With Renal Cell Cancer (MK-3475-031)
Condition: Renal Cell Cancer
Interventions: Drug: Pembrolizumab Pre-Resection;   Procedure: Surgical Resection;   Drug: Pembrolizumab Post-Resection
32 Recruiting Study of Atezolizumab + Bevacizumab in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma
Condition: Advanced Non-Clear Cell Kidney Cancer
Interventions: Drug: Bevacizumab;   Drug: Atezolizumab
33 Recruiting Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-line Sunitinib: a Phase I/II Trial
Conditions: Renal Cell Carcinoma;   Kidney Cancer
Interventions: Drug: Sunitinib;   Drug: Isoquercetin;   Drug: Placebo
34 Recruiting Sunitinib Malate With or Without Gemcitabine Hydrochloride in Treating Patients With Advanced Kidney Cancer That Cannot Be Removed By Surgery
Condition: Kidney Cancer
Interventions: Drug: gemcitabine hydrochloride;   Drug: sunitinib malate
35 Recruiting Ibrutinib and Nivolumab in Treating Patients With Previously-Treated Metastatic Kidney Cancer
Conditions: Metastatic Renal Cell Cancer;   Stage IV Renal Cell Cancer
Interventions: Drug: Ibrutinib;   Drug: Nivolumab
36 Not yet recruiting Intermittent Nivolumab in Metastatic Renal Cell Carcinoma Patients
Condition: Metastatic Renal Cell Carcinoma
Intervention: Drug: Nivolumab
37 Recruiting A Phase 2 Study of the MET Kinase Inhibitor INC280 in Papillary Renal Cell Cancer
Condition: Papillary Renal Cell Carcinoma
Intervention: Drug: INC280
38 Recruiting Perfusion CT Monitoring to Predict Treatment Efficacy in Renal Cell Carcinoma
Condition: Metastatic Renal Cell Cancer
Intervention: Procedure: perfusion computed tomography
39 Not yet recruiting CM082 Combined With Everolimus in Chinese Patients With Metastatic Renal Cell Carcinoma
Condition: Renal Cell Cancer Metastatic
Interventions: Drug: CM082 combined with everolimus;   Drug: CM082;   Drug: Everolimus
40 Recruiting Therapeutic Drug Monitoring of Sunitinib and Pazopanib in Advanced or Metastatic Renal Cell Carcinoma
Condition: Metastatic Renal Cell Cancer
Interventions: Drug: Pazopanib;   Drug: Sunitinib

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.